# Verzenio

NDC: 0002-5337
Generic name: abemaciclib
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170928

FDA application: NDA208716

## Active ingredients

- ABEMACICLIB: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-5337"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-5337
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be4bc0de-0fdc-4d46-8d25-be43c79e6a06